Final analysis of the phase III KEYNOTE-042 study: Pembrolizumab (Pembro) versus platinum-based chemotherapy (Chemo) as first-line therapy for patients (Pts) with PD-L1-positive locally advanced/metastatic NSCLC

TSK Mok, YL Wu, I Kudaba, DM Kowalski, BC Cho, HZ Turna, G de Castro, V Srimuninnimit, KK Laktionov, I Bondarenko, K Kubota, C Caglevic, B Karaszewska, T Dang, L Yin, J Penrod, G Lopes

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)38
JournalAnnals of Oncology
Issue numberSuppl.2
Publication statusPublished - Apr 2019
Externally publishedYes
EventEuropean Lung Cancer Congress (ELCC) - Geneva, Switzerland
Duration: 10 Apr 201913 Apr 2019

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this